Literature DB >> 26149693

Folate receptor expression on murine and human adipose tissue macrophages.

Michael J Hansen1, N Achini Bandara, Philip S Low.   

Abstract

OBJECTIVE AND
DESIGN: Adipose tissue macrophages (ATMs) have been implicated in a number of obesity-related diseases. Because the activated macrophages associated with many types of autoimmune and inflammatory diseases express a folate receptor (FR) that can be exploited for FR-targeted drug delivery, we examined the visceral adipose tissue of obese mice and humans to determine whether ATMs also express FR that are accessible by folate conjugates. MATERIAL OR
SUBJECTS: C57BL/6 or FATSO mice fed on either a low- or high-fat diet were used in murine studies. Human adipose tissue were obtained from healthy volunteers during adipose reduction surgery.
METHODS: Visceral adipose tissue was collected from both obese mice and humans, collagenase digested, and stained with folate-Oregon Green and antibodies for macrophage markers including F4/80, mannose receptor (CD206), CD11b, and CD11c. Cells were then examined for expression of the above markers by flow cytometry. Furthermore, the ability of folate conjugates to target the FR-expressing ATMs in obese mice was evaluated in vivo.
RESULTS: A subset of the ATMs harvested from obese mice were found to express FR. Subpopulations of ATMs also simultaneously express both pro- and anti-inflammatory markers, and FR is expressed on both subsets. We then demonstrate that FR-expressing ATMs can be targeted with folate-linked fluorescent dyes in vivo.
CONCLUSIONS: FR are expressed on multiple subsets of ATMs and these subsets can be targeted with folate-linked drugs, allowing for the possible development of FR-targeted therapies for obesity-related inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26149693     DOI: 10.1007/s00011-015-0849-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  41 in total

1.  Apoptotic cells induce arginase II in macrophages, thereby attenuating NO production.

Authors:  Axel M Johann; Vera Barra; Anne-Marie Kuhn; Andreas Weigert; Andreas von Knethen; Bernhard Brüne
Journal:  FASEB J       Date:  2007-04-24       Impact factor: 5.191

Review 2.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 3.  Monocyte recruitment and foam cell formation in atherosclerosis.

Authors:  Yuri V Bobryshev
Journal:  Micron       Date:  2005-11-09       Impact factor: 2.251

4.  Release of transforming growth factor-beta (TGF-beta) and fibronectin by alveolar macrophages in airway diseases.

Authors:  A M Vignola; P Chanez; G Chiappara; A Merendino; E Zinnanti; J Bousquet; V Bellia; G Bonsignore
Journal:  Clin Exp Immunol       Date:  1996-10       Impact factor: 4.330

5.  Hydrogen peroxide stimulates macrophage vascular endothelial growth factor release.

Authors:  M Cho; T K Hunt; M Z Hussain
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-05       Impact factor: 4.733

6.  Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages.

Authors:  Amaya Puig-Kröger; Elena Sierra-Filardi; Angeles Domínguez-Soto; Rafael Samaniego; María Teresa Corcuera; Fernando Gómez-Aguado; Manohar Ratnam; Paloma Sánchez-Mateos; Angel L Corbí
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

7.  Macrophage production of basic fibroblast growth factor in the fibroproliferative disorder of alveolar fibrosis after lung injury.

Authors:  C Henke; W Marineili; J Jessurun; J Fox; D Harms; M Peterson; L Chiang; P Doran
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

8.  Folate receptor beta as a potential delivery route for novel folate antagonists to macrophages in the synovial tissue of rheumatoid arthritis patients.

Authors:  Joost W van der Heijden; Ruud Oerlemans; Ben A C Dijkmans; Huiling Qi; Conny J van der Laken; Willem F Lems; Ann L Jackman; Maarten C Kraan; Paul P Tak; Manohar Ratnam; Gerrit Jansen
Journal:  Arthritis Rheum       Date:  2009-01

Review 9.  Obesity, adiponectin and vascular inflammatory disease.

Authors:  Noriyuki Ouchi; Shinji Kihara; Tohru Funahashi; Yuji Matsuzawa; Kenneth Walsh
Journal:  Curr Opin Lipidol       Date:  2003-12       Impact factor: 4.776

10.  Increased macrophage migration into adipose tissue in obese mice.

Authors:  Da Young Oh; Hidetaka Morinaga; Saswata Talukdar; Eun Ju Bae; Jerrold M Olefsky
Journal:  Diabetes       Date:  2011-12-21       Impact factor: 9.461

View more
  5 in total

1.  Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex.

Authors:  Yan Tie; Heng Zheng; Zhiyao He; Jingyun Yang; Bin Shao; Li Liu; Min Luo; Xia Yuan; Yu Liu; Xiangxian Zhang; Hongyi Li; Min Wu; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2020-01-22

Review 2.  Nanomedicines for dysfunctional macrophage-associated diseases.

Authors:  Hongliang He; Shobha Ghosh; Hu Yang
Journal:  J Control Release       Date:  2017-01-03       Impact factor: 9.776

3.  Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.

Authors:  Chunxia Yao; Tina Veleva; Larry Scott; Shuyi Cao; Luge Li; Gong Chen; Prince Jeyabal; Xiaolu Pan; Katherina M Alsina; Issam Abu-Taha; Shokoufeh Ghezelbash; Corey L Reynolds; Ying H Shen; Scott A LeMaire; Wilhelm Schmitz; Frank U Müller; Ali El-Armouche; N Tony Eissa; Christine Beeton; Stanley Nattel; Xander H T Wehrens; Dobromir Dobrev; Na Li
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

4.  Therapy of spinal cord injury by folic acid polyethylene glycol amine-modified zeolitic imidazole framework-8 nanoparticles targeted activated M/Ms.

Authors:  Qi Li; Yue Guo; Chang Xu; Jiachen Sun; Fanzhuo Zeng; Sen Lin; Yajiang Yuan
Journal:  Front Bioeng Biotechnol       Date:  2022-09-15

5.  Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex.

Authors:  Yan Tie; Heng Zheng; Zhiyao He; Jingyun Yang; Bin Shao; Li Liu; Min Luo; Xia Yuan; Yu Liu; Xiangxian Zhang; Hongyi Li; Min Wu; Xiawei Wei
Journal:  Signal Transduct Target Ther       Date:  2020-01-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.